These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9576951)

  • 1. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.
    Nagane M; Levitzki A; Gazit A; Cavenee WK; Huang HJ
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5724-9. PubMed ID: 9576951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
    Nagane M; Coufal F; Lin H; Bögler O; Cavenee WK; Huang HJ
    Cancer Res; 1996 Nov; 56(21):5079-86. PubMed ID: 8895767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
    Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
    Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor.
    Nagane M; Narita Y; Mishima K; Levitzki A; Burgess AW; Cavenee WK; Huang HJ
    J Neurosurg; 2001 Sep; 95(3):472-9. PubMed ID: 11565870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
    Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
    Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications.
    Nagane M; Lin H; Cavenee WK; Huang HJ
    Cancer Lett; 2001 Jan; 162 Suppl():S17-S21. PubMed ID: 11164186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
    Latha K; Li M; Chumbalkar V; Gururaj A; Hwang Y; Dakeng S; Sawaya R; Aldape K; Cavenee WK; Bogler O; Furnari FB
    Int J Cancer; 2013 Feb; 132(3):509-20. PubMed ID: 22729867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance.
    Kojima H; Endo K; Moriyama H; Tanaka Y; Alnemri ES; Slapak CA; Teicher B; Kufe D; Datta R
    J Biol Chem; 1998 Jul; 273(27):16647-50. PubMed ID: 9642215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of hydrogen peroxide production and Bax expression by caspase-3(-like) proteases in tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma cells.
    Simizu S; Umezawa K; Takada M; Arber N; Imoto M
    Exp Cell Res; 1998 Jan; 238(1):197-203. PubMed ID: 9457072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
    Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
    Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
    Yu XD; Wang SY; Chen GA; Hou CM; Zhao M; Hong JA; Nguyen DM; Schrump DS
    Cancer J; 2007; 13(2):105-13. PubMed ID: 17476138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
    Lamothe B; Aggarwal BB
    J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
    Learn CA; Hartzell TL; Wikstrand CJ; Archer GE; Rich JN; Friedman AH; Friedman HS; Bigner DD; Sampson JH
    Clin Cancer Res; 2004 May; 10(9):3216-24. PubMed ID: 15131063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells.
    Srinivasan A; Li F; Wong A; Kodandapani L; Smidt R; Krebs JF; Fritz LC; Wu JC; Tomaselli KJ
    J Biol Chem; 1998 Feb; 273(8):4523-9. PubMed ID: 9468507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex.
    Medema JP; Scaffidi C; Krammer PH; Peter ME
    J Biol Chem; 1998 Feb; 273(6):3388-93. PubMed ID: 9452459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I insulin-like growth factor receptor activation regulates apoptotic proteins.
    Singleton JR; Dixit VM; Feldman EL
    J Biol Chem; 1996 Dec; 271(50):31791-4. PubMed ID: 8943217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
    Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z
    Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain.
    Yiin JJ; Hu B; Schornack PA; Sengar RS; Liu KW; Feng H; Lieberman FS; Chiou SH; Sarkaria JN; Wiener EC; Ma HI; Cheng SY
    Mol Cancer Ther; 2010 Apr; 9(4):929-41. PubMed ID: 20371720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.